000 01185 a2200301 4500
005 20250516185042.0
264 0 _c20140908
008 201409s 0 0 eng d
022 _a1865-3774
024 7 _a10.1007/s12185-013-1490-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTurtle, Cameron J
245 0 0 _aChimeric antigen receptor modified T cell therapy for B cell malignancies.
_h[electronic resource]
260 _bInternational journal of hematology
_cFeb 2014
300 _a132-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aCell Engineering
650 0 4 _aCells, Cultured
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xadverse effects
650 0 4 _aLeukemia, B-Cell
_ximmunology
650 0 4 _aReceptors, Antigen, T-Cell
_xchemistry
650 0 4 _aRecombinant Fusion Proteins
_xmetabolism
650 0 4 _aT-Lymphocytes
_ximmunology
773 0 _tInternational journal of hematology
_gvol. 99
_gno. 2
_gp. 132-40
856 4 0 _uhttps://doi.org/10.1007/s12185-013-1490-x
_zAvailable from publisher's website
999 _c23367774
_d23367774